Key facts
- This page summarizes Shawnte Mitchell's Form 3 filing for Olema Pharmaceuticals, Inc. (OLMA).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 28 Feb 2025, 16:15.
Shawnte Mitchell - 18 Feb 2025 Form 3 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)
- Reporting relationship
- CHIEF LEGAL OFFICER
- Issuer ticker
- OLMA
- Reported as of
- 18 Feb 2025
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 28 Feb 2025, 16:15:49 UTC
- Prior SEC filing
- 09 Mar 2022
- Next SEC filing
- 03 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Shane Kovacs, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Shawnte Mitchell filed Form 3 for Olema Pharmaceuticals, Inc. (OLMA) on 28 Feb 2025.
Change
- Previous filing in this sequence was filed on 09 Mar 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.